Ivarmacitinib: all 37 studies that test it

Page 1 of 1. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.

• JAK1 Inhibitor Ivarmacitinib for Improving Pancreatic Islet Function in T1DNot yet recruitingNCT07845955Phase 2
• Ivarmacitinib Versus Glucocorticoids in Mild-to-Moderate Systemic Lupus ErythematosusNot yet recruitingNCT07814664Phase 2/3
• Efficacy and Safety of Switching to Ivarmacitinib in Patients With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to Interleukin-4 Receptor Alpha(IL-4Rα) Inhibitors: A Prospective, Multicenter, Real-World StudyNot yet recruitingNCT07550452Not applicable
• Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell CarcinomaRecruitingNCT07505186Phase 2
• Efficacy and Safety of Ivarmacitinib Monotherapy in the Treatment of csDMARDs-IR Rheumatoid ArthritisNot yet recruitingNCT07452445Phase 4
• Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's ArteritisNot yet recruitingNCT07451665Phase 4
• A Clinical Study on the Efficacy and Safety of Ivarmacitinib in Preventing aGVHD After HLA-matched TransplantationNot yet recruitingNCT07381114Phase 1/2
• Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune IntoleranceNot yet recruitingNCT07313202Phase 2
• Treatment of Moderate-to-Severe Atopic Dermatitis With Ivarmacitinib in Adolescents and AdultsNot yet recruitingNCT07276620Not applicable
• A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar PustulosisRecruitingNCT07270003Not applicable
• Efficacy and Safety of Ivarmacitinib in the Treatment of Patients With Polymyalgia RheumaticaNot yet recruitingNCT07266168Not applicable
• A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental VitiligoRecruitingNCT07251595Phase 2
• SHR0302 Combined With PD-1/PD-L1 Inhibition for Treatment naïve or Acquired Resistant to Immunology NSCLCNot yet recruitingNCT06925048Phase 2
• Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell LymphomaRecruitingNCT06519526Phase 2
• Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell LymphomaNot yet recruitingNCT05900089Phase 1
• A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative ColitisRecruitingNCT05181137Phase 3
• A Phase II Study in Adult Patients With Moderate to Severe Atopic DermatitisCompletedNCT04162899Phase 2Results posted
• A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.CompletedNCT03675477Phase 2Results posted
• Ivarmacitinib for Refractory Behcet's SyndromeWithdrawnNCT07634848Phase 2
• A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial to Evaluate the Safety and Pharmacokinetic Profile of Single and Multiple Dose Escalation Topical Dermal Administration of SHR0302 Alkali Gel in Healthy SubjectsCompletedNCT07098117Phase 1
• A Trial of SHR0302Base in Patients With VitiligoActive, not recruitingNCT06790862Phase 2
• A SHR0302 BA Study on Healthy SubjectsCompletedNCT06202612Phase 1
• To Assess SHR0302 Oral Solutions and Tablets in Healthy Subjects Clinical Studies of Relative BioavailabilityCompletedNCT05856058Phase 1
• Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia AreataActive, not recruitingNCT05470413Phase 3
• A Pharmacokinetic Study to Evaluate the Drug Interaction Between SHR0302 and CYP Substrates in Healthy VolunteersCompletedNCT05392127Phase 1
• A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial SpondyloarthritisStatus unknownNCT05324631Phase 3
• Study on the Bioavailability of SHR0302 in Healthy SubjectsCompletedNCT04712838Phase 1
• A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Ankylosing SpondylitisCompletedNCT04481139Phase 2/3
• A Phase II Study in Patients With Alopecia AreataCompletedNCT04346316Phase 2
• A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid ArthritisCompletedNCT04333771Phase 3
• Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic ImpairmentCompletedNCT04293029Phase 1
• SHR0302 and Steroid As First Line Therapy for Chronic GVHDCompletedNCT04146207Early Phase 1
• A Phase II Study in Patients With Moderate to Severe Active Crohn's DiseaseCompletedNCT03677648Phase 2
• Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) PatientsCompletedNCT03254966Phase 2
• Effect of a High-fat Meal on the Pharmacokinetics of SHR0302 and Mass Balance Study in Healthy SubjectsStatus unknownNCT02892370Phase 1
• Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) PatientsStatus unknownNCT02665910Phase 1
• First-in-Human Single Ascending Dose of SHR0302Status unknownNCT02423538Phase 1

← Ivarmacitinib overview